• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS SMART PORT CT; SMART PORT CT SINGLE TITANIUM PORT SYSTEM WITH ATTACHABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS SMART PORT CT; SMART PORT CT SINGLE TITANIUM PORT SYSTEM WITH ATTACHABLE Back to Search Results
Catalog Number CT80STPD
Device Problems Fracture (1260); Migration (4003)
Patient Problems Unspecified Infection (1930); Infiltration into Tissue (1931)
Event Date 12/01/2018
Event Type  Injury  
Manufacturer Narrative
The device is not available to be returned to the manufacturer for evaluation.The results of the investigation will be sent via a follow up medwatch.Reference (b)(4).
 
Event Description
A patient reported experiencing an issue with an angiodynamics port.The following was reported via the customer service "contact us now" submission box: "my name is [redacted], i am a receiver of one of your medical ports.During the removal of the port after the cancer was in remission, the tip of your port, broke off and is now inside my heart on the superior vena cava and right ventricle of my heart.I need to speak to someone in the legal depart ment.Or atleast someone in your administrative department.At (b)(6) where im currently undergoing treatment do to some infection that this caused.(b)(6) im in (b)(6) " further follow up determined that the device was explanted in (b)(6) of 2018.The tip fragment has been in situ since this date as it was determined that it would be too risky to remove.Patient has reported experiencing ongoing infections, including endocarditis, as a result of the fragment.Patient was unable to provide brand name, upn or lot number of device.
 
Manufacturer Narrative
Additional information received: brand name of port.The customer's reported complaint description of patient infection cannot be confirmed given the patient centric nature of this serious adverse event (sae).The reported complaint of catheter tubing tip was detached and retained in the patient could also not be confirmed since no complaint sample was returned.Without receiving a complaint sample for evaluation a definitive root cause for this event could not be determined.A four-year ship history report was performed for account number (b)(4) from 01-jan-2014 to 01-jan-2018 to cover any port upn shipped to this account that would not be expired in all of 2017.Review of this shr shows that only one port upn ((b)(6), smartport) was shipped to this customer in this four-year time period.Affected items tab updated with this upn, lot number is still unknown.In lieu of a reported lot number, the ship history report (shr) was reviewed for item number ((b)(6)) in order to ascertain all shipments in 2017.The lot(s) obtained through the shr are: 5116069, 5126587, 5128735, 5131142, 5148498, 5196614 and 5196911.Each lot number had one port item shipped for a total of 7 ports shipped in 2017.A review of the device history records was performed for the indicated lots for any deviations related to the reported failure mode of the complaint.The review confirms that the lots met all material, assembly and performance specifications; i.E.No ncr associated with reported failure mode.Labeling review: the directions for use (dfu) that is provided in the port kit contains the following directions and precautions: contraindications: · catheter insertion in the subclavian vein medial to the border of the first rib, an area which is associated with higher rates for pinch-off.Warnings: · do not use syringes smaller than 10 ml syringe when accessing the port as system damage can occur.Flushing occluded catheters with small syringes can create excessive pressures within the port system.Failure to ensure patency of the catheter prior to power injection studies may result in port system failure and patient injury may occur.· do not power inject through a port system that exhibits signs of clavicle-first rib compression or pinch-off as it may result in port system failure and patient injury may occur.Absence of a blood return or a poor blood return can be a sign of a potential complication such as occlusion, kinking, breakage, pinch-off syndrome, fibrin formation, thrombosis or malposition.This should be evaluated prior to device usage.· a blood return should be present prior to usage of device for any therapy or testing.· do not attempt to measure the patient's blood pressure on the arm in which a peripheral system is located, since catheter occlusion or other damage to the catheter could occur.· if the patient complains of pain, or there is swelling when the device is flushed or when medication or contrast media is administered, evaluate the device for infiltration, proper needle placement, and potential complications such as occlusion, kinking, breakage, pinch-off syndrome, thrombosis or malposition.Failure to assess these complaints or observations can lead to device failure.Precautions: to avert device damage and/or patient injury during catheter placement: · avoid accidental device contact with sharp instruments and mechanical damage to the catheter material.· use only smooth-edged atraumatic clamps or forceps.· do not use the catheter if there is any evidence of mechanical damage or leaking.· avoid sharp or acute angles during implantation which could compromise the patency of the catheter lumen.· carefully follow the catheter to port connection technique provided in the dfu to ensure proper device connection and to avoid catheter damage.· assure tight connection between port body and catheter.· after implantation or any treatment via the port, the system should be flushed with normal saline for injection per institutional protocol.Potential complications: use of an angiodynamics port system involves potential risks normally associated with the insertion or use of any implanted device or indwelling catheter including but not limited to: catheter disconnection or migration.Catheter embolization.Catheter fragmentation.Catheter pinch-off.Infection.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART PORT CT
Type of Device
SMART PORT CT SINGLE TITANIUM PORT SYSTEM WITH ATTACHABLE
Manufacturer (Section D)
ANGIODYNAMICS
10 glens falls technical park
glens falls NY 12801
Manufacturer (Section G)
ANGIODYNAMICS
10 glens falls technical park
glens falls NY 12801
Manufacturer Contact
alexandra invencio
26 forest street
marlborough, MA 01752
5086587990
MDR Report Key17907089
MDR Text Key325342202
Report Number1317056-2023-00137
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Catalogue NumberCT80STPD
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/26/2023
Initial Date FDA Received10/10/2023
Supplement Dates Manufacturer Received12/06/2023
Supplement Dates FDA Received12/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age58 YR
Patient SexMale
Patient Weight113 KG
-
-